Interact to see
Advertisement
Advertisement
ADNRX vs FSMAX
ADNRX vs FSMAX Comparison
Open Charts ADNRX vs FSMAX
ADNRX vs FSMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. FSMAX commentary
Sep 09, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Buy and FSMAX is a Buy.
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. ADNRX (162M). FSMAX pays higher dividends than ADNRX: FSMAX (0.49) vs ADNRX (0.00). ADNRX was incepted earlier than FSMAX: ADNRX (6 years) vs FSMAX (15 years). ADNRX (1.18) is less costly to investors than FSMAX (0.04). ADNRX is a more actively managed with annual turnover of: 46.00 vs. FSMAX (23.00). ADNRX (0) and FSMAX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 17.49 vs. ADNRX (16.09). FSMAX return over 5 years is better than : 35.40 vs. ADNRX (-45.75).
| ADNRX | FSMAX | ADNRX / FSMAX | |
| Total Expense Ratio | 1.05 | 0.04 | 3,000% |
| Annual Report Gross Expense Ratio | 1.18 | 0.04 | 3,371% |
| Fund Existence | 6 years | 15 years | - |
| Gain YTD | 14.616 | 16.609 | 88% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 162M | 40.1B | 0% |
| Annual Yield % from dividends | 0.00 | 0.49 | - |
| Returns for 1 year | 16.09 | 17.49 | 92% |
| Returns for 3 years | 103.43 | 69.03 | 150% |
| Returns for 5 years | -45.75 | 35.40 | -129% |
| Returns for 10 years | N/A | 138.83 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers